Abstract
Routine coronal paraffin-sections through the dorsal frontal and parieto-occipital cortex of a total of sixty cases with divergent causes of death were immunohistochemically (IHC) stained with an antibody against TMEM119. Samples of cerebrospinal fluid (CSF) of the same cases were collected by suboccipital needle-puncture, subjected to centrifugation and processed as cytospin preparations stained with TMEM119. Both, cytospin preparations and sections were subjected to computer-assisted density measurements. The density of microglial TMEM119-positive cortical profiles correlated with that of cytospin results and with the density of TMEM119-positive microglial profiles in the medullary layer. There was no statistically significant correlation between the density of medullary TMEM119-positive profiles and the cytospin data. Cortical microglial cells were primarily encountered in supragranular layers I, II, and IIIa and in infragranular layers V and VI, the region of U-fibers and in circumscribed foci or spread in a diffuse manner and high density over the white matter. We have evidence that cortical microglia directly migrate into CSF without using the glympathic pathway. Microglia in the medullary layer shows a strong affinity to the adventitia of deep vessels in the myelin layer. Selected rapidly fatal cases including myocardial infarcts and drowning let us conclude that microglia in cortex and myelin layer can react rapidly and its reaction and migration is subject to pre-existing external and internal factors. Cytospin preparations proved to be a simple tool to analyze and assess complex changes in the CNS after rapid fatal damage. There is no statistically significant correlation between cytospin and postmortem interval. Therefore, the quantitative analyses of postmortem cytospins obviously reflect the neuropathology of the complete central nervous system. Cytospins provide forensic pathologists a rather simple and easy to perform method for the global assessment of CNS affliction.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Traumatic brain injury (TBI), vascular, infectious, neoplastic, and neurodegenerative diseases impact blood-brain-barrier (BBB) and cerebrospinal fluid (CSF)-brain-barrier (CSFB). These barriers become leaky, and, as a consequence, larger peptides, microbial metabolic substances, cytoskeletal, and intracellular neuronal and glial elements can be identified in the CSF [1, 2]. Since the CSF is permanently resorbed, interstitial fluid (ISF) influx carrying degenerated proteins and waste products from all parts of the central nervous system (CNS) replenish resorbed CSF [3]. Cellular, microbial, metabolic, and structural proteins are considered as biomarkers that act as surrogate markers of CNS neuropathology, e.g., after traumatization [4,5,6,7,8,9,10,11,12,13,14,15]. Research and diagnosis of enhanced CSF-cell density after inflammatory and tumor-related brain affliction have a long history [16,17,18]. Analysis of CSF cellular type and density estimations were so far not in the focus of forensic neuropathological diagnostic methods and received only marginal attention in forensic practice [19]. This is surprising since the CSF is anatomically well-protected by the skull and the spinal canal. Therefore, its topography predestines this body fluid to preserve the integrity of whole cells [20].
In addition to astrocytes, microglia, the resident macrophages of the CNS and the first cellular defense line whenever damage occurs (regardless if traumatic or not), play a critical and strategic role in mediating CNS inflammation [21, 22]. In 2016, TMEM119, a trans-membranous molecule [23], was proved to be a specific and robust microglial marker. Since that time, even though it can be downregulated in some contexts [24], it has served for the immunohistochemical demonstration of microglia response to fatal TBI [25] or intoxications [26]. In addition, modified histochemical protocols could detect microglia in postmortem CSF samples of cases with TBI [13].
In the present study, we have analyzed the quantitative correlation between the cortical and subcortical density of TMEM119-positive microglial profiles in paraffin sections with the density of TMEM119-positive microglial cells in cytospin preparations of the CSF after different fatalities and postmortem intervals (PMI). The objective of our study was to establish a protocol monitoring CSF density of TMEM119-positive microglial cells as a surrogate marker for the assessment of complex neuropathological processes in the CNS.
Material and methods
Sampling and processing
CSF was collected by semi-sterile puncture of the suboccipital space prior to opening of the skull and removal of the brain in the course of forensic autopsies at the Institute of Forensic Medicine, University of Wuerzburg. Unknown, non-natural and violent causes of death were the reason for forensic postmortem investigations. Small routine diagnostic tissue samples for histopathologic diagnoses were cut out from unfixed coronal sections through the dorsomedial frontal and parieto-occipital lobes. Qualitative and quantitative data from the tissue samples consisting of cortical gyri and adherent parts of the white matter were compared with corresponding data of cytospin preparations. Our study included 60 cases, 27 females and 33 males ranging in age between 24 and 97 years. Anamnestic data and PMI (from 10 to 713 h) are summarized in Table 1). This research study has been approved by the ethics committee of the University of Würzburg (local number 203/15).
The dissected cortical gyri were fixed in buffered 4% formalin, dehydrated, and paraffin embedded. The paraffin blocks were cut with a sliding microtome at 6 µm. Consecutive sections were mounted on microscope slides and routinely stained by Mayer’s hemalaun-eosin (HE) and immunohistochemically processed with a commercially available antibody against TMEM119 in a dilution of 1:1000 (Sigma, St. Louis, USA) [25] as primary antibody. The MultiLink Streptavidin-Peroxidase-Kit (BioGenex, San Ramon, USA) was used as secondary antibody. Control slides were stained by omitting the primary antibodies to test for unspecific staining in all staining charges.
For macroscopic orientation, digital images of HE and TMEM119 stained sections were taken with a Canon MP-E65 macrolens mounted on a Canon EOS MKII single lens reflex camera at 1.5 fold magnification depicting the complete sections. High-resolution RAW-files were adjusted for maximal contrast and transformed into TIF-files.
Microscopic digital images of the immunostained sections were taken with a Leica digital camera DMC 5400 mounted on a Leica DM6 B microscope at a constant using × 100 magnification (both Leica Microsystems Corporation, Wetzlar, Germany).
Five randomized images per case and slide free from staining and cutting artefacts were taken to obtain representative samples for each case. The total area of the images comprised 5.8 mm2 (1.16 mm2 per single photograph). For quantitative evaluation of the sections, an image processing software (Leica LASX, Wetzlar, Germany) was used as described before [26]. Prior to digital image analysis, parameters of cell morphology (size of profiles and staining intensity) were defined for the TMEM119 antibody. These parameters were invariably used throughout the measurements.
The software automatically copied the data into an Excel-macro table (Microsoft Corporation, Redmond, USA. The number of IH-positive profiles (microglial perikarya + major processes emanating from the perikarya) per field of view was expressed as number of immuno-positive profiles per square millimeter or simply density per mm2.
CSF samples were immediately centrifuged at 5000 rpm for 5 min at 4 °C and cytospin preparations were stained with the antibody mentioned above using an adapted protocol for immunocytochemistry [13] and identical dilutions .
The CSF samples were analyzed in the same way as the tissue sections. A total of five images were obtained from each cytospin preparation using the same lens and identical total magnification. The five samples per cytospin were taken in a clockwise manner at 12 o’clock, 3 o’clock, 6 o’clock, and 9 o’clock together with the center of each circular cytospin preparation (Fig. 2a).
Prerequisites for inclusion of subsequent cases in 2018 and 2019 successful CSF-sampling by suboccipital puncture, the application of an immunocytochemical TMEM119-protocol (cytospin preparation), and the availability of formalin-fixed paraffin-embedded tissue from the prefrontal and parietooccipital cortex of brains after successful CSF retrieval. Our 6-µm-thick paraffin sections included different cortical areas with more or less typical lamination and neuronal cell densities in the six isocortical layers. An exact areal diagnosis was illusive in 6 µm HE-stained paraffin sections. The presence of numerous stacked granule and small pyramidal cells at the border of the supragranular layer IIIc and infragranular layer V facilitated the distinction of pre- and postcentral cortical tissue.
Based on the number of TMEM119-positive cells in CSF, four categories (groups) were defined:
Case group strongly positive when > 30 TMEM119-positive profiles were detected, case group positive when > 10–30 TMEM119-positive profiles, case group weak to negative when 1–9 TMEM119-positive profiles, and case group negative when 0 TMEM119-positive profiles were detected.
Statistical analysis
Excel Version 16.15 (Microsoft Corporation) and GraphPad Prism software version 8 (GraphPad Software, La Jolla, USA) were used for statistical evaluation: the Shapiro-Wilk normality test was used to test the distribution of the samples, an ordinary one-way ANOVA was used for parametric data of samples in addition to the post hoc Tukey’s multiple comparisons test, but a Kruskal-Wallis test was calculated for nonparametric data followed by Dunn’s test to avoid repetitive testing failure. Spearman coefficients were reported for the correlations, respectively. Adjusted p values equal or below 0.05 were considered statistically significant.
Results
Our observations and measurements were exclusively based on routine neuropathologic diagnoses of cases from our local forensic institute. It comprised a wide spectrum of lethal causes ranging from TBI to cardiovascular fatalities (CVF) (Table 1). High-resolution RAW or JPG files were indispensable to get an overview over the paraffin sections. The files could be magnified up to eight times without loss of details. At this magnification, intensely stained dot-like profiles proved to be single TMEM119-positive microglial cells. Their processes could not be recognized in the macroscopic overview. However, with microscopic lenses (× 100) their fine structure could be easily assessed (rectangles in Fig. 1a,b). In cases with lower cortical densities up to 100 profiles, TMEM119-positive microglial cells were not uniformly spread over the cortex but proved to be arranged in a more or less distinct laminar pattern (Fig. 1c-f). They clustered in the region of layer IIIa including the outer surface of layer II. In cytospin-TMEM119-negative cases the density of TMEM119-positive cortical microglial profiles was generally low. They appeared to be immersed in a diffusely stained neuropil (Fig. 1a,c). In cytospin-TMEM119-positive cases the density of cortical TMEM119-positive microglial cells increased and the neuropil became more intensely stained (Fig. 1b.d). In addition, TMEM119-positive profiles were also encountered in increasing numbers in layers IIIb, c and conspicuously in layers V and VI. The increased density of thin TMEM119-positive microglial processes most likely caused an increased diffuse neuropil staining in macroscopic overviews (Fig. 1e,f). U-fibers, a system of short-ranged association fibers, course between the lower border of layer VI and long-ranged projection- and association fibers comprising the central medullary ray. The layer of U-fibers together with layer VI and deep layer V proved to be a second hotspot of enhanced microglial density (Fig. 1f). TMEM119-positive microglial profiles were not confined to the region of U-fibers. They were also encountered in the deeper parts of the central medullary ray of cortical gyri that were continuous with long-range fiber systems in the hemispheric semi-oval center. We saw widely distributed foci with low number, confluent foci with a higher number of glial profiles and, finally, TMEM119-positive microglia densely populating the complete medullary region (Fig. 1a,b).
TMEM119-positive microglia cells and the vascular system of the human central nervous system showed tissue-specific relationships. Profiles of bigger cortical arteries or veins were rarely visible in our paraffin-embedded tissue. However, venous and arterial profiles of different caliber were more frequently encountered in the medullary layer (Fig. 2c,d). Microglia and vessels of the medullary layer appeared to have a close relationship. Microglia distant from vessels were obviously intact, however, with decreasing distance to vessels microglial cells displayed fewer fine processes (similar to those microglial cells at layer I/II border) and were found nearby or within the perivascular space (Fig. 2d). Our paraffin sections were subject to considerable shrinkage and the relationship of perivascular TMEM119-positive profiles to the basal lamina could not be established with reasonable precision.
The topographical relationship of TMEM119-positive microglia to cortical vessels appeared to be less intimate (Fig. 2c). Vascular profiles were frequently encountered at the fundus of cortical gyri. At variance with vessels in the medullary layer, microglial cells rarely lost their processes to associate with the perivascular wall. We found far more vessel-independent single or groups of microglial cells with increasing density traversing the border of layer II with the deep parts of layer I. In this region, TMEM119-positive microglial cells seemed to divest their processes and dive into a spongious outer part of layer I (Fig. 2c thin arrow) or to align sub- and suprapially (Fig. 2b). Positive microglial profiles were also encountered in the arachnoidal space (Fig. 2b thin arrows) that in situ is flooded by CSF.
Our sample of a total of 60 cases comprised 27 female and 33 male cases with different causes of death and PMI. The effect of these parameters are depicted in a heatmap (Fig. 6). Brain-weight versus age correlated negatively and versus sex positively, cardiopulmonary resuscitation (CPR) versus PMI correlated negatively and versus CSF-intensity positively. There was no correlation between PMI and CSF-intensity and between CSF-intensity and brain weight.
Our qualitative assessment of cortical and medullary TMEM119-positive microglial density was generally in line with computer assisted immuno-positive cell-density measurements in microscopic slides through cortex and cytospin preparations (Fig. 2a,b) This correlation proved to be statistically significant (Fig. 3). The high density of cortical TMEM119-positive microglial cells was accompanied with high density of microglial cells in the medullary layer (Fig. 1b,d,f). This impression was confirmed by the statistical analysis of cortex and white matter (Fig. 4). However, medullary layer microglial cell density did not show a statistically significant correlation with cytospin microglial measurements (Fig. 5).
Cortical glial density varied from 6 to 459, medullary layer density from 2 to 512, and cytospin density from 0 to 303. Correlating cortical TMEM119-positivity with causes of death yielded no uniform trend (unclear cause of death 459, acute heart failure with history of multiple older infarctions 318, drowning 294). Drowning was associated with the highest medullary layer TMEM119-positivity (512) in given cases in the absence of TMEM119-positive microglial perikarya in cytospin preparations. There were 11 cases with cortical TMEM119-positive profiles ranging from 216 to 459. In 6 of these cases cytospin-densities varied from 0 to 3, and in two cases with lethal myocardial infarction cytospin-positive preparations yielded 130 and 300 profiles. However, in these two cases the heart had experienced several preceding episodes of infarcts. TBI of the skull was associated with absent cytospin-profiles and 31 cortical profiles whereas after fracture of the 2nd vertebra we measured 256 TMEM119-positive profiles in the cytospin preparation and 48 cortical TMEM119-positive profiles.
Discussion
Our sample contained a high number of cases that widely differed by age, causes of death, preexisting illness, and postmortem intervals. Male to female ratio was 27 females versus 33 male cases. Main confounding factors are depicted in a heatmap (Fig. 6) that proved the influence of age and sex on brain weight. In this aspect, our cases are in line with the majority of studies on these parameters [27, 28]. The negative correlation between CPR efforts and PMI implies the limitations of therapeutic CPR application. A victim of a traffic accident has a higher probability to be re-animated compared to a cadaver with initial signs of extended PMI or beginning autolysis. On the other hand, an extended PMI did not necessarily impact the staining intensity or cell density of CSF cytospins. In addition, the CSF density of TMEM-119-positive cells in our CPR-cases correlated positively. This could imply that CPR is able to mobilize transition of parenchymal TMEM119-positive microglia to CSF. It remains to be investigated to what extent and after what time intervals CPR intervention is able to mobilize microglia from the CNS. Nevertheless, the occipital subarachnoid space provides a long-term repository for the demonstration of TMEM119-positive microglia [20].
Brain tissue deterioration is subject to environmental factors and autolysis. Taken together, these confounding factors can have a massive impact on histological and immunohistochemical diagnosis and quantification of results. However, even cases with an extremely long PMI showed HE-stained neuronal and TMEM119-positive glial perikarya and their processes given the cadavers were quickly stored at 4 °C upon arrival. Cerebrovascular fatalities were always detrimental for CNS tissue quality and staining. Our IHC protocols were based on autoclaving paraffin sections glued on poly-l-lysine coated microscopic slides. In many cases, marked uneven staining was observed in the periphery of glued sections. This phenomenon indicates incipient peripheral floating off together with tears and missing parts. Another phenomenon was decreasing IHC staining of microglia from gyral crests, to walls and fundi with preserved HE staining of neuronal or glial nuclei and nucleoli irrespective of their topography. One explanation could be the effect of formalin fixation which is particularly marked in complete unsliced brains. In these scenarios we focused our quantitative analyses on well-stained regions of affected sections. Furthermore, our qualitative and quantitative analyses were confined to small regions of dorsomedial frontal and parieto-occipital lobes. These regions do not necessarily reflect the impact of circumscribed or extended lesions in other cerebral parts.
Our findings on fatalities with different causes most likely contributed to the considerable intra- and interindividual variations of the data depicted in Figs. 3, 4, and 5 and Table 1.
Cortical and medullary microglia can obviously react rapidly. Rapidly fatal myocardial infarctions were associated with absent or low density of TMEM119-positive profiles in cytospin preparations. The same was true for one case with drowning. On the other hand, two cases with lethal myorcardial infarction had an obvious history of multiple preceding infarcts. They were characterized by a high density of cortical and cytospin profiles. Local cortical or subcortical microglia can obviously react rapidly whereas CSF-transition of microglia is more time-consuming.
It is a matter of debate, how and when TMEM119-positive profiles originating in cerebral cortex and white matter gain access to the subarachnoidal and ventricular CSF. Migration of neuromelanin-loaded microglia targeting brainstem vessels and entering the cerebral circulation in Pick’s disease was already described by Scholz [29], and this original observation was extended and is presently summarized under the concept of the glymphatic pathway [30,31,32,33,34,35,36,37]. However, in this recent concept, migrating microglia is described to be enclosed by the basal lamina of meningeal arteries and/or veins and it is not debated when, where and how cortical or medullary TMEM119-positive microglia enter the CSF. We provide evidence that cortical TMEM119-positive microglia directly gain access to or are expelled into the CSF. Unfortunately, we had no periventricular white matter in our archived cases to show a migration of medullary TMEM119-positive microglia through intact ventricular ependyma or leakage through a defective one. The highly gyrated isocortex provides a far higher surface for resident microglial migration/leakage into the CSF compared with deep white matter microglia. This could explain the statistically significant contribution of cortical microglia to microglial cytospin positivity and the absence of a statistically significant contribution of white matter microglia to the latter in our cases. On the other hand, the significant quantitative correlation of white matter TMEM119 positive profiles to TMEM-positive cortical profiles obviously reflects the close functional relationship between cortex and white matter. In summary, postmortem sampling and quantitative assessment of TMEM119 IH-staining of CSF is a simple and reliable tool to diagnose the impact of different causes of death on the CNS in the course of forensic autopsies.
Limitations
We have analyzed a relevant number of cases categorized by density of TMEM119-positive profiles in cytospin preparations and density measurements of microglial profiles in cortex and white matter. Our small-sized paraffin sections do not necessarily reflect the impact of more massively affected remote regions in our correlation studies. The same is true for differences in IHC-staining of gyral crest versus wall and fundi. We could not address the question of concomitant local and distant neuron loss and the role of remote antero- and retrograde degeneration as drivers in microglia reaction, proliferation, and recycling. In addition, the anamnestic data including PMI, biographical, and clinical data are vague and incomplete. Only TBIs and other sudden fatalities in the absence of preexisting diseases could elucidate different scenarios of glial reaction in cytospin preparations, cortex, and medullary layer. A correlative quantitative study on the extent and topography of TBI in the complete CNS of healthy young adults versus TMEM119-positive microglia in the CSF would be free of confounding diseases and could corroborate a straightforward relation between CNS lesion and local/CSF microglial reaction.
Conclusion
Our observations on laminar distribution of microglia and its quantitative interactions with TMEM119-positive microglia in the CSF provide new insights into a fast-reacting highly dynamic system. Cytospin analyses reflect a versatile neurobio- and pathobiology of human microglia. They supplement the growing concept of glymphatic pathways and warrant further studies to clarify diverging quantitative differences in cases with similar causes of death together with the reason of selective laminar vulnerability at the border of isocortical layers I/II and deep layers V/VI including U-fibers. Forensic autopsy tissue proved invaluable in addressing fundamental neurobiologic and pathologic questions and interpretation of results of animal studies [38, 39].
References
Daneman R, Prat A (2015) The blood-brain barrier. Cold Spring Harb Perspect Biol 7:a020412
Ballabh P, Braun A, Nedergaard M (2004) The blood-brain barrier: an overview structure, regulation, and clinical implications. Neurobiol Dis 16:1–13
Benveniste H, Lee H, Volkow N (2017) The glymphatic pathway: waste removal from CNS via cerebrospinal fluid transport. Neuroscientist 23:454–465
Agoston DV, Shutes-David A, Peskind E (2017) Biofluid biomarkers of traumatic brain injury. Brain Inj 31:1195–1203
Harel A, Kvist M, Nuutinen S, Välimaa L (2016) Biomarkers of traumatic brain injury temporal changes in body fluids. eNeuro 3:1–13
Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, Manley GT (2018) An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn 18:165–180
Yokobori S, Hosein K, Burks S, Sharma I, Gajavelli S, Bullock R (2013) Biomarkers for the clinical differential diagnosis in traumatic brain injury-a systematic review. CNS Neurosci Ther 19:556–565
Zetterberg H, Smith D, Blennow K (2013) Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol 9:201
Ondruschka B, Sieber M, Kirsten H, Franke H, Dreßler J (2018) Measurement of cerebral biomarkers proving traumatic brain injury in post-mortem body fluids. J Neurotrauma 17:2044–2055
Sieber M, Dreßler J, Franke H, Pohlers D, Ondruschka B (2018) Post-mortem biochemistry of NSE and S100B: a supplemental tool for detecting a lethal traumatic brain injury. J Forensic Leg Med 55:65–73
Bohnert S, Reinert C, Trella S, Schmitz W, Ondruschka B, Bohnert M (2021) Metabolomics in postmortem cerebrospinal fluid diagnostics: a state-of-the-art method to interpret central nervous system-related pathological processes. Int J Legal Med 135:183–191
Zwirner J, Bohnert S, Franke H, Garland J, Hammer N, Möbius D, Tse R, Ondruschka B (2021) Assessing protein biomarkers to detect lethal acute traumatic brain injuries in cerebrospinal fluid. Biomolecules 11:1577
Bohnert S, Wirth C, Schmitz W, Trella S, Monoranu CM, Ondruschka B, Bohnert M (2021) Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury. Int J Leg Med 135:1525–1535
Trautz F, Franke H, Bohnert S, Hammer N, Müller W, Stassart R, Tse R, Zwirner J, Dreßler J, Ondruschka B (2019) Survial-time dependent increase in neuronal IL-6 and astroglial GFAP expression in fatally injured human brain tissue. Sci Rep 9:11771
Zwirner J, Kulakofsky R, Fitzek A, Schröder A, Bohnert S, Franke H, Renne T, Tse R, Ondruschka B (2022) Forensic biomarkers of lethal traumatic brain injury. Int J Legal Med. https://doi.org/10.1007/s00414-022-02785-2
Reiber H (1994) Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 122:189–203
Reiber H (1995) Die diagnostische Bedeutung neuroimmunologischer Reaktionsmuster im Liquor cerebrospinalis. Labormedizin 19:444–442
Felgenhauer K, Beuche W (1999) Labordiagnostik neurologischer Erkrankungen. Liquoranalytik und -zytologie Diagnose- und Prozessmarker Thieme Stuttgart
Thomsen H, Klinggräff Cv, Rudolph J (1997) Blutungsaltersbestimmung im Liquor nach Schüttel-Trauma“ eines Säuglings. Rechtsmedizin 7:162–164
Bohnert S, Ondruschka B, Bohnert M, Schuhmann MK, Monoranu CM (2019) Post-mortem cerebrospinal fluid diagnostics: cytology and immuncytochemistry. A method suitable for routine use to interpret pathological processes in the central nervous system. Int J Legal Med 133:1141–1146
Kumar A, Loane D (2012) Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun 26:1191–1201
Loane DJ, Kumar A (2016) Microglia in the TBI brain: The good, the bad, and the dysregulated. Exp Neurol 275:316–327
Satoh J, Kino Y, Asahina N, Takitani M, Miyoshi J, Ishida T, Saito Y (2016) TMEM119 marks a subset of microglia in the human brain. Neuropathol 36:39–49
Young K, Gardner R, Sariana V, Whitman S, Bartlett M, Falk T, Morrison H (2021) Can quantifying morphology and TMEM119 expression distinguish between microglia and infiltrating macrophages after ischemic stroke and reperfusion in male and female mice? J Neuroinflammation 18:2–15
Bohnert S, Seiffert A, Trella S, Bohnert M, Distel L, Ondruschka B, Monoranu C (2020) TMEM119 as a specific marker of microglia reaction in traumatic brain injury in post mortem examination. Int J Legal Med 134:2167–2176
Bohnert S, Georgiades K, Monoranu CM, Bohnert M, Büttner A, Ondruschka B (2021) Quantitative evidence of suppressed TMEM119 microglial immunochemistry in fatal morphine intoxications. Int J Legal Med 135:2315–2322
Svennerholm L, Bostrom K, Jungbjer B (1997) Changes in weight and compositions of major membrane components of human brain during the span of adult human life of swedes. Acta Neuropathol 94:345–352
Spann W, Dustmann H (1965) Das menschliche Hirngewicht und seine Abhängigkeit von Lebensalter, Körperlänge, Todesursache und Beruf. Dtsch Z Gesamte Gerichtl Med 56:299–317
Scholz W (1957) Für die allgemeine Histopathologie degenerative Prozesse bedeutsame morphologische histochemische und strukturphysiologische Daten In Lubarsch O Henke F Rössle R (eds) Handbuch der speziellen pathologischen Anatomie und Histologie 13 P1A 42-265 Springer Berlin
Albargothy N, Sharp M, Gatherer M, Morris A, Weller R, Hawkes C, Carare R (2017) Investigating the lymphatic drainage of the brain: essential skils and tools. Methods Mol Biol 11
Hablitz L, Nedergaard M (2021) The glymphatic system: a novel component of fundamental neurobiology. J Neurosci 41:7698–7711
Jessen N, Munk A, Lundgaard I, Nedergaard M (2015) The glymphatic system: a beginners’s guide. Neurochem Res 40:2583–2599
Wardlaw J, Benveniste H, Nedergaard M, Zlokovic B, Mestre H, Lee H, Doubal F, Brown R, Ramirez J, Macintosh B (2020) Perivascular spaces in the brain: anatomy, physiology and pathology. Nat Rev Neurol 16:137–153
Albargothy N, Johnston D, MacGregor-Sharp M, Weller R, Verma A, Hawkes C, Carare R (2018) Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periaterial basement membrane pathsways. Acta Neuropathol 136:139–152
Benveniste H, Lee H, Volkow N (2017) The glymphatic pathway: waste removal from the CNS via cerebrospinal fluid transport. Neuroscientist 23:454–465
Da Mesquita S, Fu Z, Kipnis J (2018) The meningeal lymphatic system: a new player in neurophysiology. Neuron 100:375–388
Natale G, Limanaqi F, Busceti C, Mastroiacovo F, Nicoletti F, Puglisi-Allegra S, Fornai F (2021) Glymphatic System as a Gateway to connect neurodegeneration from periphery to CNS. Front Neurosci 15:639140
Smith A, Dragunow M (2014) The human side of microglia. Trends Neurosci 37:125–135
Cuadros M, Sepulveda M, Martin-Oliva D, Marin-Teva J, Neubrand V (2022) Microglia and microglia-like cells: similar but different. Front Cell Neurosci 16:816439
Acknowledgements
We would like to thank the technical assistants Heiko Besenfelder and Max Perschneck, Institute of Forensic Medicine, University of Wuerzburg, for their excellent support in collecting the specimens, Michaela Hartmann, Department of Neuropathology, Institute of Pathology, University of Wuerzburg, as well as the team of the CSF laboratory of the Neurological University Hospital for their help with the preparations and stains.
The authors would also like to thank Gerdi Zimmermann (Commissioned Sworn Translator, Gundelfingen, Germany) for correcting the English language of the manuscript. This paper is dedicated to Donata, the daughter of SB.
Ethical approval
This study has been reviewed and approved by the ethics committee of the University of Wuerzburg (203/15).
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed consent
Not applicable
Conflict of interest
The authors declare that they have no potential conflict of interest.
Research involving human participants and/or animals
None
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bohnert, S., Trella, S., Preiß, U. et al. Density of TMEM119-positive microglial cells in postmortem cerebrospinal fluid as a surrogate marker for assessing complex neuropathological processes in the CNS. Int J Legal Med 136, 1841–1850 (2022). https://doi.org/10.1007/s00414-022-02863-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-022-02863-5